Complex And Simple Appendicitis: REstrictive or Liberal postoperative Antibiotic eXposure (CASA RELAX) using Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR): study protocol for a randomized controlled trial

Daniel Dante Yeh, Gabrielle E Hatton, Claudia Pedroza, Gerd Pust, Alejandro Mantero, Nicholas Namias, Lillian S Kao, Daniel Dante Yeh, Gabrielle E Hatton, Claudia Pedroza, Gerd Pust, Alejandro Mantero, Nicholas Namias, Lillian S Kao

Abstract

Objectives: After appendectomy for simple or complicated appendicitis, the optimal duration of postoperative antibiotics (postop abx) is unclear and great practice variability exists. We propose to compare restrictive versus liberal postop abx using a hierarchical composite endpoint which includes patient-centered outcomes and accounts for duration of antibiotic exposure.

Methods/design: Participants with simple or complicated appendicitis undergoing appendectomy are randomly assigned to either restricted or liberal strategy. Eligible subjects declining randomization will be recruited to enroll in an observation only cohort. The primary endpoint is an ordinal scale of mutually exclusive clinical outcomes with within-category rankings determined by duration of antibiotic exposure. Subjects in both randomized and observation only cohorts will be analyzed as intention-to-treat, per-protocol, and as-treated. Exploratory Bayesian analyses will be performed.

Conclusion: The complex and simple appendicitis: restrictive or liberal postoperative antibiotic exposure multicenter randomized controlled trial will enroll surgical appendectomy patients and seeks to analyze if a strategy of restricted (compared with liberal) postoperative antibiotics results in similar clinical outcomes with the benefit of reduced antibiotic exposure.

Trial registration number: NCT05002829.

Keywords: Appendicitis.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Sawyer RG, Claridge JA, Nathens AB, Rotstein OD, Duane TM, Evans HL, Cook CH, O'Neill PJ, Mazuski JE, Askari R, et al. . Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 2015;372:1996–2005. 10.1056/NEJMoa1411162
    1. Yeh DD, Eid AI, Young KA, Wild J, Kaafarani HMA, Ray-Zack M, Kana'an T, Lawless R, Cralley AL, Crandall M, et al. . Multicenter study of the treatment of appendicitis in America: acute, perforated, and gangrenous (MUSTANG), an East multicenter study. Ann Surg 2021;273:548–56. 10.1097/SLA.0000000000003661
    1. Lawless RA, Cralley A, Qian S, Vasileiou G, Yeh DD, Allmond SL, Alouidor R, Barth N, Behrens B, Bradley M, Group EAS, et al. . Antibiotics after simple (acute) appendicitis are not associated with better clinical outcomes: a Post-Hoc analysis of an East multi-center study. Surg Infect 2021;22:504–8. 10.1089/sur.2019.348
    1. Bou Zein Eddine S, Dodgion CM, Qian S, Trevino C, De Moya MA, Yeh DD,. EAST Appendicitis Research Group . Complicated Appendicitis: Are Extended Antibiotics Necessary? A Post Hoc Analysis of the EAST Appendicitis "MUSTANG" Study. J Surg Res 2020;247:508–13. 10.1016/j.jss.2019.09.054
    1. Chammas M, Pust GD, Hatton G, Pedroza C, Kao L, Rattan R, Namias N, Yeh DD,. EAST Appendicitis Study Group . Outcomes of restricted versus liberal post-operative antibiotic use in patients undergoing appendectomy: a DOOR/RADAR post hoc analysis of the East appendicitis MUSTANG study. Surg Infect 2022;23:489–94. 10.1089/sur.2021.287
    1. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83. 10.1016/0021-9681(87)90171-8
    1. Alvarado A. A practical score for the early diagnosis of acute appendicitis. Ann Emerg Med 1986;15:557–64. 10.1016/S0196-0644(86)80993-3
    1. Tominaga GT, Staudenmayer KL, Shafi S, Schuster KM, Savage SA, Ross S, Muskat P, Mowery NT, Miller P, Inaba K, et al. . The American association for the surgery of trauma grading scale for 16 emergency general surgery conditions: disease-specific criteria characterizing anatomic severity grading. J Trauma Acute Care Surg 2016;81:593–602. 10.1097/TA.0000000000001127
    1. Kaafarani HMA, Mavros MN, Hwabejire J, Fagenholz P, Yeh DD, Demoya M, King DR, Alam HB, Chang Y, Hutter M, et al. . Derivation and validation of a novel severity classification for intraoperative adverse events. J Am Coll Surg 2014;218:1120–8. 10.1016/j.jamcollsurg.2013.12.060
    1. Mavros MN, Velmahos GC, Larentzakis A, Yeh DD, Fagenholz P, de Moya M, King DR, Lee J, Kaafarani HMA. Opening Pandora's box: understanding the nature, patterns, and 30-day outcomes of intraoperative adverse events. Am J Surg 2014;208:626–31. 10.1016/j.amjsurg.2014.02.014
    1. Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 1992;111:518–26.
    1. Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien P-A. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg 2013;258:1–7. 10.1097/SLA.0b013e318296c732
    1. Evans SR, Rubin D, Follmann D, Pennello G, Huskins WC, Powers JH, Schoenfeld D, Chuang-Stein C, Cosgrove SE, Fowler VG, et al. . Desirability of outcome ranking (door) and response adjusted for duration of antibiotic risk (radar). Clin Infect Dis 2015;61:800–6. 10.1093/cid/civ495
    1. Smith VA, Coffman CJ, Hudgens MG. Interpreting the results of intention-to-treat, Per-Protocol, and As-Treated analyses of clinical trials. JAMA 2021;326:433–4. 10.1001/jama.2021.2825
    1. , Flum DR, Davidson GH, Monsell SE, Shapiro NI, Odom SR, Sanchez SE, Drake FT, Fischkoff K, Johnson J, et al. . CODA Collaborative . A randomized trial comparing antibiotics with appendectomy for appendicitis. N Engl J Med 2020;383:1907–19. 10.1056/NEJMoa2014320
    1. Walsh M, Srinathan SK, McAuley DF, Mrkobrada M, Levine O, Ribic C, Molnar AO, Dattani ND, Burke A, Guyatt G, et al. . The statistical significance of randomized controlled trial results is frequently fragile: a case for a fragility index. J Clin Epidemiol 2014;67:622–8. 10.1016/j.jclinepi.2013.10.019
    1. Tignanelli CJ, Napolitano LM. The fragility index in randomized clinical trials as a means of optimizing patient care. JAMA Surg 2019;154:74–9. 10.1001/jamasurg.2018.4318
    1. Team RC . R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2017. .
    1. Goodrich BG J, Ali I, Brilleman Srstanarm. Bayesian applied regression modeling via Stan. 2020 [R package version 2.21.1. .
    1. Mui LM, Ng CSH, Wong SKH, Lam Y-H, Fung TMK, Fok K-L, Chung SSC, Ng EKW. Optimum duration of prophylactic antibiotics in acute non-perforated appendicitis. ANZ J Surg 2005;75:425–8. 10.1111/j.1445-2197.2005.03397.x
    1. Kim DY, Nassiri N, Saltzman DJ, Ferebee MP, Macqueen IT, Hamilton C, Alipour H, Kaji AH, Moazzez A, Plurad DS, et al. . Postoperative antibiotics are not associated with decreased wound complications among patients undergoing appendectomy for complicated appendicitis. Am J Surg 2015;210:983–9. 10.1016/j.amjsurg.2015.07.001
    1. Kimbrell AR, Novosel TJ, Collins JN, Weireter LJ, Terzian HWT, Adams RT, Beydoun HA. Do postoperative antibiotics prevent abscess formation in complicated appendicitis? Am Surg 2014;80:878–83. 10.1177/000313481408000921
    1. van Rossem CC, Schreinemacher MHF, van Geloven AAW, Bemelman WA,. Snapshot Appendicitis Collaborative Study Group . Antibiotic duration after laparoscopic appendectomy for acute complicated appendicitis. JAMA Surg 2016;151:323–9. 10.1001/jamasurg.2015.4236
    1. van den Boom AL, de Wijkerslooth EML, van Rosmalen J, Beverdam FH, Boerma E-JG, Boermeester MA, Bosmans JWAM, Burghgraef TA, Consten ECJ, Dawson I, et al. . Two versus five days of antibiotics after appendectomy for complex acute appendicitis (APPIC): study protocol for a randomized controlled trial. Trials 2018;19:263. 10.1186/s13063-018-2629-0

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit